Search Results - "Hamamoto, Yu"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Expert consensus on pharmacotherapy for tic disorders in Japan by Hamamoto, Yu, Fujio, Miyuki, Nonaka, Maiko, Matsuda, Natsumi, Kono, Toshiaki, Kano, Yukiko

    Published in Brain & development (Tokyo. 1979) (01-06-2019)
    “…We aimed to clarify the current status of pharmacotherapy for tic disorders and comorbidities in Japan. We used a systematic survey to collate the consensus of…”
    Get full text
    Journal Article
  2. 2

    Cefepime‐induced encephalopathy: Neural mass modeling of triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) by Tamune, Hidetaka, Hamamoto, Yu, Aso, Naofumi, Yamamoto, Naoki

    Published in Psychiatry and clinical neurosciences (01-01-2019)
    “…Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed…”
    Get full text
    Journal Article
  3. 3

    Efficient Prediction of Vitamin B Deficiencies via Machine-Learning Using Routine Blood Test Results in Patients With Intense Psychiatric Episode by Tamune, Hidetaka, Ukita, Jumpei, Hamamoto, Yu, Tanaka, Hiroko, Narushima, Kenji, Yamamoto, Naoki

    Published in Frontiers in psychiatry (20-02-2020)
    “…Vitamin B deficiency is common worldwide and may lead to psychiatric symptoms; however, vitamin B deficiency epidemiology in patients with intense psychiatric…”
    Get full text
    Journal Article
  4. 4

    The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL): A Validation in Japanese Patients by Goto, Ryunosuke, Matsuda, Natsumi, Nonaka, Maiko, Hamamoto, Yu, Eriguchi, Yosuke, Fujiwara, Mayu, Suzuki, Akane, Yokoyama, Yukari, Kano, Yukiko

    Published in Frontiers in psychiatry (03-01-2022)
    “…Though Gilles de la Tourette's syndrome (GTS) has significant impact on the quality of life of its patients, measures of health-related quality of life…”
    Get full text
    Journal Article
  5. 5
  6. 6